Metropolitan Life Insurance Company (MetLife)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-7,465
| Closed | -$294K | – | 2484 |
|
2023
Q2 | $294K | Hold |
7,465
| – | – | 0.01% | 552 |
|
2023
Q1 | $182K | Sell |
7,465
-859
| -10% | -$20.9K | 0.01% | 710 |
|
2022
Q4 | $178K | Buy |
8,324
+805
| +11% | +$17.2K | 0.01% | 761 |
|
2022
Q3 | $135K | Hold |
7,519
| – | – | 0.01% | 854 |
|
2022
Q2 | $72.3K | Hold |
7,519
| – | – | ﹤0.01% | 1268 |
|
2022
Q1 | $127K | Sell |
7,519
-22,329
| -75% | -$376K | ﹤0.01% | 1056 |
|
2021
Q4 | $499K | Buy |
29,848
+2,602
| +10% | +$43.5K | 0.01% | 1432 |
|
2021
Q3 | $442K | Buy |
27,246
+1,938
| +8% | +$31.5K | 0.01% | 1549 |
|
2021
Q2 | $160K | Buy |
25,308
+12,813
| +103% | +$80.9K | ﹤0.01% | 2313 |
|
2021
Q1 | $77.2K | Sell |
12,495
-10,012
| -44% | -$61.9K | ﹤0.01% | 2482 |
|
2020
Q4 | $156K | Sell |
22,507
-2,737
| -11% | -$18.9K | ﹤0.01% | 2109 |
|
2020
Q3 | $142K | Buy |
25,244
+9,567
| +61% | +$54K | ﹤0.01% | 2001 |
|
2020
Q2 | $80K | Buy |
+15,677
| New | +$80K | ﹤0.01% | 2381 |
|
2016
Q4 | – | Sell |
-22,221
| Closed | -$1.03M | – | 2653 |
|
2016
Q3 | $1.03M | Hold |
22,221
| – | – | 0.01% | 1263 |
|
2016
Q2 | $1.13M | Buy |
22,221
+5,319
| +31% | +$271K | 0.01% | 1191 |
|
2016
Q1 | $714K | Buy |
16,902
+224
| +1% | +$9.46K | 0.01% | 1363 |
|
2015
Q4 | $1.31M | Hold |
16,678
| – | – | 0.01% | 1049 |
|
2015
Q3 | $676K | Hold |
16,678
| – | – | ﹤0.01% | 1428 |
|
2015
Q2 | $868K | Buy |
+16,678
| New | +$868K | 0.01% | 1385 |
|
2015
Q1 | – | Sell |
-11,079
| Closed | -$497K | – | 2485 |
|
2014
Q4 | $497K | Buy |
11,079
+1,005
| +10% | +$45.1K | ﹤0.01% | 1769 |
|
2014
Q3 | $392K | Hold |
10,074
| – | – | ﹤0.01% | 1879 |
|
2014
Q2 | $426K | Buy |
10,074
+338
| +3% | +$14.3K | ﹤0.01% | 1956 |
|
2014
Q1 | $348K | Sell |
9,736
-292
| -3% | -$10.4K | ﹤0.01% | 2055 |
|
2013
Q4 | $324K | Buy |
+10,028
| New | +$324K | ﹤0.01% | 2129 |
|